CA2651607A1 - Mirtazapine for the treatment of neuropathic pain - Google Patents

Mirtazapine for the treatment of neuropathic pain Download PDF

Info

Publication number
CA2651607A1
CA2651607A1 CA002651607A CA2651607A CA2651607A1 CA 2651607 A1 CA2651607 A1 CA 2651607A1 CA 002651607 A CA002651607 A CA 002651607A CA 2651607 A CA2651607 A CA 2651607A CA 2651607 A1 CA2651607 A1 CA 2651607A1
Authority
CA
Canada
Prior art keywords
mirtazapine
treatment
pain
neuropathic pain
neuropathic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002651607A
Other languages
English (en)
French (fr)
Inventor
Andrea Houghton
Gerardus Stephanus Franciscus Ruigt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme BV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2651607A1 publication Critical patent/CA2651607A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002651607A 2006-05-22 2007-05-21 Mirtazapine for the treatment of neuropathic pain Abandoned CA2651607A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06114316 2006-05-22
EP06114316.0 2006-05-22
PCT/EP2007/054872 WO2007135123A2 (en) 2006-05-22 2007-05-21 Mirtazapine for the treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
CA2651607A1 true CA2651607A1 (en) 2007-11-29

Family

ID=37006417

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002651607A Abandoned CA2651607A1 (en) 2006-05-22 2007-05-21 Mirtazapine for the treatment of neuropathic pain

Country Status (8)

Country Link
EP (1) EP2026814A2 (enExample)
JP (1) JP2009537601A (enExample)
AR (1) AR061046A1 (enExample)
CA (1) CA2651607A1 (enExample)
MX (1) MX2008014287A (enExample)
PE (1) PE20080455A1 (enExample)
TW (1) TW200808804A (enExample)
WO (1) WO2007135123A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6452954B2 (ja) * 2013-05-16 2019-01-16 国立大学法人千葉大学 癌転移抑制剤
PL3261645T3 (pl) 2015-02-27 2021-12-06 Dechra Limited Pobudzanie apetytu, zarządzanie utratą masy ciała, i leczenie anoreksji u psów i kotów

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211171B1 (en) * 1998-05-19 2001-04-03 Dalhousie University Use of antidepressants for local analgesia
HUP0204050A3 (en) * 2000-01-19 2004-09-28 Akzo Nobel Nv Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone
US7074961B2 (en) * 2000-09-26 2006-07-11 The Brigham And Women's Hospital, Inc. Antidepressants and their analogues as long-acting local anesthetics and analgesics
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
TW200538100A (en) * 2004-04-21 2005-12-01 Akzo Nobel Nv Mirtazapine salts

Also Published As

Publication number Publication date
TW200808804A (en) 2008-02-16
EP2026814A2 (en) 2009-02-25
WO2007135123A3 (en) 2008-03-13
JP2009537601A (ja) 2009-10-29
WO2007135123A2 (en) 2007-11-29
MX2008014287A (es) 2008-11-18
AR061046A1 (es) 2008-07-30
PE20080455A1 (es) 2008-06-25

Similar Documents

Publication Publication Date Title
Shapira et al. Treatment of binge-eating disorder with topiramate: a clinical case series
Yazigi et al. Prophylactic ondansetron is effective in the treatment of nausea and vomiting but not on pruritus after cesarean delivery with intrathecal sufentanil-morphine
Buckenmaier III et al. Anaesthetic agents for advanced regional anaesthesia: a North American perspective
Wiles et al. Local anaesthetics and adjuvants–future developments
DK3085363T3 (en) PHARMACEUTICAL ADMINISTRATION TO PROVIDE LOCAL ANALYSIS, LOCAL ANESTHESIA OR NERVOUS BLOCKS
PL207845B1 (pl) Spray donosowy do dostarczania kompozycji farmaceutycznej zawierającej fentanyl i zastosowanie soli fentanylu do wytwarzania środka leczniczego
JP2010504926A (ja) 痛みの治療のための混合されたＯＲＬ１／μ−アゴニスト
RS56523B1 (sr) Tapentadol za sprečavanje i lečenje depresije i anksioznosti
US20110034565A1 (en) Psycho-pharmaceuticals
PT100850B (pt) Composicoes farmaceuticas contendo uma mistura sinergica de um agente uricosurico, em especial,de probenecid, com um agente antagonista de aminoacidos excitantes, em especial,um derivado de quinoxalina substituido e sua utilizacao no tratamento de doencas neurodegenerativas
US11285099B2 (en) Topical phenytoin for use in the treatment of peripheral neuropathic pain
Fournier et al. Intrathecal sufentanil is more potent than intravenous for postoperative analgesia after total-hip replacement
ES2649492T3 (es) (S)-pirlindol o sus sales farmacéuticamente aceptables para uso en medicina
MXPA02007095A (es) Combinacion de farmacos para el tratamiento de la depresion y desordenes relacionados que comprenden mirtazapina.
Dahl et al. Immediate and prolonged effects of pre–versus postoperative epidural analgesia with bupivacaine and morphine on pain at rest and during mobilisation after total knee arthroplasty
Bufalari et al. Preemptive carprofen for peri-operative analgesia in dogs undergoing Tibial Plateau Leveling Osteotomy (TPLO): a prospective, randomized, blinded, placebo controlled clinical trial
KR102232198B1 (ko) 의약으로서 사용되기 위한 (r)-펄린돌 및 약학적으로 허용 가능한 그의 염
CA2651607A1 (en) Mirtazapine for the treatment of neuropathic pain
US20180221380A1 (en) Use of 5H-Dibenz/b,f/Azepine-5-Carboxamide Derivatives for Treating Fibromyalgia
US20070270413A1 (en) Mirtazapine for the treatment of neuropathic pain
Mohammed et al. Intrathecal versus intravenous dexmedetomidine in characteristics of bupivacaine spinal block in lower abdominal surgery
Hung et al. Cutaneous analgesia and systemic toxicity of carbetapentane and caramiphen in rats
CA2629347A1 (en) Synergistic combinations of norketamine and opioid analgesics
Johnson Treatment of acute pain in cats
EP1762239B1 (en) Lofexidine for intraspinal administration

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20140521